| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K19103580 | CTRPv2 | pan-cancer | AAC | 0.15 | 0.0001 |
| mRNA | lapatinib | GDSC1000 | pan-cancer | AAC | 0.2 | 0.0002 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.22 | 0.0002 |
| mRNA | austocystin d | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0003 |
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | -0.22 | 0.0004 |
| mRNA | BRD-K41597374 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0004 |
| mRNA | Bax channel blocker | CTRPv2 | pan-cancer | AAC | 0.13 | 0.001 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | 0.16 | 0.001 |
| mRNA | BMS-754807 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.001 |
| mRNA | sitagliptin | CTRPv2 | pan-cancer | AAC | 0.25 | 0.002 |